Monday, 23 August 2021

Heart Rate Monitor Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

 Market Highlights

Wearable medical devices have now gained popularity from last few years owing to their increasing use among the health-conscious people and technological penetration in various regions across the globe. Heart rate monitors are of two types namely, wearable and non-wearable devices. Chest strap, wrist strap, and strapless devices are wearable heart rate monitors. These devices have an embedded sensor which continuously keeps a check on the heart rate of a person during various physical activities as well as when the body is at rest. Key players in the market are tapping new regions in the developing economies across the globe to take a hold of the markets. The global heart rate monitors market is driven by increasing prevalence of cardiovascular diseases and diabetes, rapidly developing technology, and increasing geriatric population across the globe, which has fueled the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1370 

According to the World Health Organization, diabetes is a major risk factor for cardiovascular diseases whose prevalence is found to be increased tremendously across the globe. The WHO stated that 422 million people across the globe are suffering from diabetes. The high cost of wearable heart rate devices may restrain the growth of the market over the assessment period. 

Regional Analysis

In the Americas, the market exhibits tremendous growth owing to an extensive use of heart rate monitors by the people and healthcare providers in hospitals and clinics. The U.S. is the largest market in the Americas owing to increasing patient population suffering from chronic diseases such as cardiovascular diseases and diabetes. The key players are engaged in product differentiation and geographical expansion to maintain their position in the market.

Europe is the second largest market followed by Asia Pacific. In Europe, the market shows growth opportunities in Germany, the U.K, and France. This growth is due to increasing availability of funds for research and development activities and rising prevalence of diabetes. Strong government support and high healthcare expenditure are driving the growth of the market.

Asia Pacific is the fastest growing market owing to increasing prevalence of diabetes and obesity and high geriatric population in developing regions such as India, China, and Japan, Additionally, increasing demand for technologically advanced wearable medical devices such as smartwatches and chest strap is further boosting the market growth. Moreover, increasing government support and presence of huge opportunity in medical device industry have together fueled the growth of the market in Asia Pacific region.

In the Middle East & Africa, the market exhibits steady growth owing to an increasing demand for healthcare services and positive growth of healthcare industry. The Middle East & African market is governed by increasing availability of tertiary healthcare services and growing awareness about cardiovascular diseases. In Africa, the market shows steady growth due to the limited availability of medical facilities, demand for primary care services, and poor economic condition in the African countries.

Segmentation

The global heart rate monitors market has been segmented on the basis of types, application, and end users. On the basis of the types, the global heart rate monitors market is segmented into wearable and non-wearable devices. The wearable devices are sub-segmented into chest strap, wrist strap, and strapless. Non-wearable devices are sub-segmented into analog and digital. Based on the application, it is segmented into sports, medical, and others. On the basis of the end users, the market is segmented into hospital & clinics, sport medicine centers, professionals, individuals, and others.

Key Players

Some of the major players in this market are Apple (U.S.), Garmin Ltd.(U.S.), Visiomed Group (France), SAMSUNG ELECTRONICS Co. Ltd. (South Korea), Nike (U.S.), Fitbit Inc. (U.S.), Mio Global (South Korea), Beurer GmbH (Germany), Omron Healthcare (Japan), Inc., LG Electronics (South Korea), nu-beca & maxcellent co. (Taiwan),  Motorola, Polar Electro (Finland), TomTom International BV (The Netherlands), Motorola Solutions, Inc. (U.S.), Sony (Japan), and others. Other players are SUUNTO (Finland), MYZONE (U.S.), Wahoo Fitness (U.S.), Moov Inc. (U.S.), Nokia (Finland), Bragi (Germany), Jabra (Germany), Decathlon (France), and Scosche Industries. (U.S.)

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/heart-rate-monitor-market-1370 

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hemifacial Spasm Market Dynamics, Segments and Supply Demand 2020-2027

 Market Highlights

Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population.

A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5533 

However, difficult diagnosis, cost of treatment, side-effects of botulinum toxin, the presence of misbranded and spurious drugs, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the review period.

It is estimated that the hemifacial spasm market is expected to grow at a CAGR 7.5% during the forecast period.

Regional Analysis:

The Americas dominate the hemifacial spasm market owing to the rising technological advancements and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion, and hospital care accounted for a share of 32.3%.

Europe holds the second position in the hemifacial spasm market. It is expected that the support provided by the government bodies for research & development and improvement in reimbursement policies in the healthcare is likely to drive the European market.

The Asia Pacific is the fastest growing hemifacial spasm market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015. An increasing prevalence rate among Asian population is also propelling the growth of the market.

The Middle East & Africa holds the lowest share of the global market due to lack of technical knowledge and poor medical facilities.

Segmentation

The global hemifacial spasm market is segmented on the basis of diagnosis, treatment, and end user.

On the basis of the diagnosis, the market is classified as a magnetic resonance imaging (MRI), computed tomography (CT or CAT scan), angiography (Arteriography), and others.

On the basis of the treatment, the market is classified as medical treatment, surgical treatment, combinational therapy, transcutaneous electric nerve stimulation (TENS) therapy, physical therapy, and others. The medical treatment is further classified into Botulinum Neurotoxin (BoNT) Injections and Pharmaceuticals. The sub-segment of Botulinum Neurotoxin (BoNT) Injections includes BoNT-A, BoNT-B, onabotulinumtoxinA, incobotulinumtoxinA, and rimabotulinumtoxinB. The sub-segment of pharmaceuticals include anticonvulsants, and GABAergic drugs. The surgical treatment is further classified into microvascular decompression (MVD), and others.

On the basis of the end user, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.

Key Players

Some of key the players in the global hemifacial spasm market are Abbott, Allergan, Inc., Cephalon Inc., GlaxoSmithKline plc, Ipsen Group, Johnson & Johnson Services, Inc., Medytox,Inc., Merz Pharma GmbH and Co. KGaA, Novartis AG, Pfizer, Revance Therapeutics, Inc., ROCHE, Sanofi S.A, Shire plc, Stryker, Sunovion Pharmaceuticals, Inc., UCB S.A., US WorldMeds, LLC., and Valeant Pharmaceuticals International, Inc.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hemifacial-spasm-market-5533 

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Cheilectomy Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Market Highlights

Factors like increasing prevalence of hallux rigidus, growing female population, rising demands for minimally invasive procedures, growing healthcare expenditure, and increasing geriatric population is estimated to drive the global cheilectomy market. However, high procedural cost, complications like deep vein thrombosis, need for repeated surgery, stiffness in the joints of the toes, and low per capita healthcare expenditure in the middle and low-income countries is estimated to restrain the market growth during the projected period.

The global cheilectomy market is expected to grow at an approximate CAGR of 7.8% during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5470 

 Segmentation

The global cheilectomy market is segmented by the method, anesthesia, medication, and end-user.

By the method, the market is segmented into open, arthroscopic, and percutaneous method.

By the anesthesia, the market is categorized into general anesthesia, local anesthesia, and regional anesthesia. By the medication, the market is segmented into prescription pain relievers, OCT, and others. By prescription the pain relievers the market is segmented into corticosteroids, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. By the OCT drugs, the market is segmented into ibuprofen, naproxen, and others. By end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.

Regional Analysis

The Americas dominate the global cheilectomy market. Well-developed healthcare sector, increasing prevalence of hallux rigidus, rising healthcare expenditure, and presence of the key players are some of the drivers for the market growth within the region. Additionally, increasing geriatric population and growing female population fuels the market growth.

Europe is the second largest cheilectomy market. Increasing prevalence of osteoarthritis, growing geriatric population, and rising healthcare expenditures within the region are some of the driving factors for the market growth. On a regional basis, Europe is divided into two regions, i.e., Western Europe and Eastern Europe. Western Europe is estimated to be the leading market within the region.

Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India & China, and presence of huge opportunity in the market. On the other hand, the Middle East & Africa has the least share in the global cheilectomy market due to the presence of poor economies which have low per capita healthcare expenditure and stringent government policies, especially in the Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Key Players

The key players for the global cheilectomy market are Henry Schein, Inc. (U.S.), STEROID S.p.A. (Italy), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Sanofi (France), Janssen Pharmaceuticals, Inc. (Belgium), PurduePharma (U.S.), ALLERGAN (Republic of Ireland), Boehringer Ingelheim International GmbH (Germany), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cheilectomy-market-5470 

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Dental Surgical & Diagnostic Devices Market: Segmentation, Industry trends and Development to 2027

 Market Highlights

Dental surgical and diagnostic devices are the medical devices used for the diagnosis and the treatment of the dental problems. Increasing prevalence of dental problems, rising geriatric population, development in the dental surgical and diagnostic devices drive the global market. Moreover, changing lifestyle and increasing consumption of drugs contributes to the growth of the market. However, high cost of the devices may hinder the growth of the market over the forecast period. 

The global dental surgical and diagnostic devices market is expecting a sound growth at a health CAGR of 11.2% during the forecasted period. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/724 

Segmentation

The global dental surgical & diagnostic devices market is segmented into product types, application and end users. The market is segmented on the basis of product type: CAD/CAM systems, dental chairs, dental radiology devices, CBCT scanners, scaling units, dental lasers. CAD/CAM systems is further segmented into full in-lab systems, stand-alone scanners, and chair-side systems. Dental radiology devices are sub-segmented into Phosphor Storage Plates (PSP), digital x-ray, accessories, dental imaging devices. Dentals lasers market is further segmented into soft tissue laser and all hard tissue laser market.  The soft tissue laser is subdivided into gas laser, diode laser, and solid state lasers.

On the basis of applications, the market is segmented into bone abnormalities, cysts, fractures, reconstructive postmortem dental profiling, and comparative dental identification. And on the basis of end users the market is segmented into dentists, hospitals, and others. 

Regional Analysis

America dominates the global dental surgical and diagnostic devices market owing to the presence of the huge geriatric population and continuously increasing patient number. According to the National Institute of Dental and Craniofacial Research (2016), in America, 80% of the adults aged 20 - 64 years have dental cavity or tooth decay. According to the Centers for Disease Control and Prevention (2015), 50% American adults aged over 30 have periodontal diseases. Furthermore, high spending on healthcare and well-developed infrastructure have also help in the growth of the market. Europe holds the second position in the global market followed by Asia Pacific.  Asia Pacific is the fastest growing market due to the presence of the huge opportunities, rising population base, increasing awareness about the dental care, and oral health hygiene, and continuously increasing demand. However, the Middle East and Africa accounts for the least market share. 

Some of the major players in the market are 3M (US), A-dec Inc. (US), Carestream Health (US), Danaher (US), American Medicals (US), Dentsply Sirona. (Germany), Ivoclar Vivadent, Inc. (Liechtenstein), Hu-Friedy Mfg. Co., LLC (US),  PLANMECA OY (Finland), Midmark Corp. (US), KaVo Kerr (US), GC Corporation (Japan), DCI (US). 

The global dental surgical & diagnostic devices market is experiencing extreme competition due to major companies are focusing on the development of new and advances devices to overcome the disadvantages of present available devices. Some major has adopted strategies of acquisitions and strategic alliances for the growth of the market. 

3M is the American multinational company focuses on the manufacturing and distribution of the number of different products. The company manufacture number of products such as dental and orthodontic products, medical products, personal protective equipment, electronic materials, and many more. Filtek, Clinpro, ESPE Peridex, Protemp Plus, and Scotchbond. 

Carestream Health, headquartered in Canada, is one of the largest corporations in Canada and involved in manufacturing of the different dental surgical and diagnostic devices such as radiology department products, medical printing products, healthcare it products.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/dental-surgical-diagnostic-devices-market-724 

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

HIDA Scan Market Foraying into Emerging Economies 2020-2027

 Market Highlights

HIDA scan is used of the diagnosis of problems related to gall bladder, liver, and bile duct. It is often used with X-ray and ultrasound. Major indications for HIDA scan are cholecystitis, bile duct obstruction, congenital abnormalities in the bile ducts, such as biliary atresia, and various postoperative complications, such as bile leaks and fistulas. Additionally, it is also used for assessment of liver transplant.

The global HIDA scan market has been evaluated as a moderately growing market and it is expected to continue growing in the near future. Increasing prevalence of various gallbladder diseases is the key factor for the market growth. Top players in the market are introducing new and advanced diagnostic and treatment options to cure gallbladder problems that are leading the growth for global HIDA scan market. Additionally, technological advancement in medical devices also accelerate the growth of the market.

The HIDA scan market is expected to grow at a CAGR of 4.2%.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5231 

Segmentation:

The global HIDA scan market is segmented on the basis of product, indication, and end user.

On the basis of product, the market is segmented into radiopharmaceuticals, HIDA Scan, and others.

On the basis of indication, the market is segmented into cholecystitis, bile duct obstruction, biliary atresia, postoperative complications, assessment of liver transplant, and others. Postoperative complications is sub-segmented into bile leaks, and fistulas.

On the basis of end user, the market is segmented into orthopedic hospitals & clinics, diagnostic centers, and others.

Regional Analysis:

America is the largest market for the global HIDA scan market across the globe owing the growth of medical device industry in developed regions such as the U.S. In America, North America dominates market owing to increasing number of specialty healthcare centers, and growing demand for innovation imaging solutions in the market.

Europe has the second largest market for the HIDA scan which is followed by Asia Pacific. Increasing healthcare expenditure, and focus on resreach and development activities by medical device manufacturers, are major drivers for the growth of HIDA scan market in European nations such as Germany, France, and U.K.  

Asia Pacific is also witnessing a rapid growth in this market which is mainly due to splendid gorwth of healthcare sector in developing countries such as India, and increasing, and rising awareness about nuclear medicine and imaging technologies. The key players are now being attracted towards Asia Pacific owing to increasing demand for diagnostic services, and rise prevalcne of chronic diseases. Asia Pacific gall bladder treatment market is expected to grow at a CAGR of 7.0% during the forecasted period. The Middle East & Africa is expected to have limited growth with respect to this market.

Major players in HIDA Scan market:

There are plenty of large and small market players which operate in this market: Houston Medical Imaging (U.S.), Bracco Diagnostic Inc. (U.S.), Buffalo MRI (U.S.), Siemens (U.S.), DDD- Diagnostics A/S (Germany), Digirad Corporation (U.S.), General Electric Company (U.S.), Koninklijke Philips N.V. (Japan), Toshiba Medical Systems Corporation (Japan), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hida-scan-market-5231 

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Point of Care Blood Gas and Electrolyte Market: Recent Industry Trends and Projected Industry Growth, 2020– 2027

 Market Highlights

Point of care blood gas and electrolyte analyzers is the new technology, which helps in reducing therapeutic turnaround time, enhancing patient satisfaction, accuracy, and help to improve hospital operations. Rising prevalence of chronic diseases and cancer across the globe, increasing the treatment of NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department, which drives the global point of care blood gas and electrolyte devices market growth. In 2017, due to changes in the regulatory policies of the U.S., R&D investment is affected to some extent. In 2016, R&D spending of the US was 527.5 billion, which grew by 1.6% in 2017. Currently, the major shares of the global market are dominated by few leading players, and they can fluctuate the costs of the products. In developing regions such as Asia Pacific the suppliers are trying to provide their products at affordable price.

The global point of care blood gas and electrolyte devices market is expected to grow at a CAGR of 7.8% during the forecast period. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5085 

Segmentation

The global point of care blood gas and electrolyte gas devices market has been segmented on the basis of types and end users.

On the basis of the types, the market is segmented into consumables and Instruments. The instrument type is sub-segmented into benchtop and portable devices. The consumable devices are further segmented into reagents, cartridges, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, home care, research institutions, and others. 

Regional Analysis

The Americas dominate the global market owing to a huge population with chronic diseases such as diabetes, kidney, and liver disease, increasing government support for research & development, and high health care expenditure. According to the WHO, in 2014, 9.7% of the total America population is having diabetes. Thus, increasing prevalence of diabetes has boosted the market growth. Additionally, changing lifestyle and the presence of major players in the market have fuelled the growth of the market.

Europe is the second largest point of care devices market across the globe, which is followed by Asia Pacific. Asia Pacific is the fastest growing market and majorly driven by India and China owing to a huge number patients with chronic diseases and rapidly growing economy. According to the WHO, 60% of the global diabetic population lives in Asia Pacific region. The healthcare expenditure of Asia Pacific has increased over the last few years, which has contributed to the growth of the market.

The Middle East and Africa region account for the least share of the global market. Whereas, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition of the region. 

Key Players

Some of the major players in this market: Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/poc-blood-gas-and-electrolyte-market-5085 

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Jaw Surgery Market Foraying into Emerging Economies 2020-2027

 Market Highlights

Jaw surgery is also called orthognathic surgery. It is a procedure that is used to correct problems ranging from major skeletal problems to minor dental irregularities. Jaw surgery is usually performed by skilled and qualified oral and maxillofacial surgeons (OMS).  The global jaw surgery market is anticipated to witness a moderate CAGR of 3.7% over the forecast period, as per the latest report launched by Market Research Future (MRFR).

The global jaw surgery market is assessed to be driven by various factors such as the rising prevalence of dental irregularities and facial skeletal deformities. Extensive use of surgical instruments generally designed to conduct jaw surgeries is pushing the global jaw surgery market over the assessment period. Other problems that can be fixed by jaw surgeries include maxillary or mandibular facial skeletal deformities, facial trauma, chronic jaw or jaw joint pain, and speech impairments. Further, jaw surgeries are also used as corrective procedures for a congenital disability, protruding jaw as well as for the improvement of the overall facial appearance.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5077 

Moreover, increasing healthcare expenditure, all over the globe, is another factor upscaling the jaw surgery market over the assessment period. Technological developments in the innovation and integration of advanced surgical devices for jaw surgeries has led to ascension in the global jaw surgery market. A surge in the research and development activities in the field of cosmetology is also bound to boost the jaw surgery market’s growth.

Market Segmentation

The global jaw surgery market has been studied for various types of instruments, indications, and end-users. The report has mentioned different types of instruments used in jaw surgery. These include elevators, curettes, forceps & needle holders, and retractors & speculums. Different indications of jaw surgery include maxillary & mandibular facial skeletal deformities, chronic jaw or jaw joint pain, speech impairments, and facial trauma. The end-users mentioned in the global jaw surgery report are hospitals and clinics.

Detailed Regional Analysis

The global jaw surgery market is studied for various regional segments to analyze the market in detail and arrive at an accurate conclusion. These regional segments include the Americas, Europe, Asia Pacific, and the Middle East & Africa. The global jaw surgery market is projected to be led by the Americas over the forecast period. Such domination can be owed to the rising demand for jaw surgeries, and an ascension noted in the number of clinics and hospitals providing such treatments. Within the Americas, North America is estimated to spearhead the regional jaw surgery market by the end of the forecast period.

Europe is estimated to trail behind the Americas fetching the second-largest share in the global jaw surgery market. A rising healthcare expenditure, with mounting government support, is pushing the regional jaw surgery market to a great extent. Within Europe, France and Germany are likely to spearhead the country-specific market for jaw surgery over the review period. This can be causative to the growing awareness of jaw surgery and its advantages towards the improvement of facial appearance. Also, comprehensive growth assessed in the medical industry is causative of the surge noted in Europe’s jaw surgery market.

Asia Pacific is anticipated to witness fastest growth in the global jaw surgery market owing to the rising per capita income, and upscaling adoption of the western culture has led to a higher demand for jaw surgeries among the general public. The Middle East & Africa is expected to showcase a steady ascension in the jaw surgery market due to lower technology penetration, along with the lack of proper healthcare infrastructure to support advanced jaw surgeries.

Key Players

The global jaw surgery market boasts the presence of various noteworthy players, including The Amato Centers for Facial Surgery (U.S.), Eurosurgical (U.K), Integra LifeSciences Corporation (U.S.), The Restful Jaw Company, LLC. (U.S.) Millennium Surgical Corp (U.S.), Novo Surgical Inc. (U.S.), Scanlan International. (U.S.), HAAG-STREIT GROUP (U.S.), and Sklar Surgical Instruments (U.S.).

Industry Update

June 2019: A seven-year-old boy from Chennai, India, suffering from Compound Composite Odontoma, recently underwent jaw surgery to get rid of 526 teeth from his lower jaw. This rare condition is when a benign tumor develops in the patient’s mouth, and teeth start growing within the tumor.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/jaw-surgery-market-5077 

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com